Cost Management Insights: SG&A Expenses for Johnson & Johnson and Wave Life Sciences Ltd.

Navigating SG&A Expenses: A Tale of Two Companies

In the ever-evolving landscape of corporate finance, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Johnson & Johnson, a healthcare giant, and Wave Life Sciences Ltd., a biotechnology innovator, offer contrasting insights into cost management from 2014 to 2023.

Johnson & Johnson's SG&A expenses have shown a slight decline, with a 9% decrease from 2014 to 2022, reflecting strategic cost management amidst global challenges. In contrast, Wave Life Sciences Ltd. experienced a staggering 1,600% increase in SG&A expenses over the same period, indicative of its aggressive growth strategy and investment in innovation.

This data underscores the diverse approaches companies take in managing operational costs. While Johnson & Johnson focuses on efficiency, Wave Life Sciences Ltd. prioritizes expansion, highlighting the dynamic nature of financial strategies in the corporate world.